Redwood Park Advisors »

Ligand Pharmaceuticals In shares owned by Redwood Park Advisors

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Redwood Park Advisors from 13F filings

Historical chart of Redwood Park Advisors investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Redwood Park Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Redwood Park Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $74k 415 177.14
2025-06-30 $47k 415 113.68

More positions owned by Redwood Park Advisors

Goldman Sachs Etf Tr Acces Treasury (GBIL)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Msci Usa Min Vol (USMV)
Dimensional Etf Trust Us Large Cap Val (DFLV)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Ssga Active Etf Tr Spdr Tr Tactic (TOTL)
Apple (AAPL)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Flexshares Tr Mornstar Upstr (GUNR)
Ishares Tr Msci Eafe Etf (EFA)
Adobe Systems Incorporated (ADBE)

View all positions for Redwood Park Advisors

Top funds holding Ligand Pharmaceuticals In

BlackRock
Vanguard Group
Henderson Group
Macquarie Group
State Street Corporation
Chicago Capital
Stephens Investment Management Group
Dimensional Fund Advisors
Massachusetts Financial Services
Congress Asset Management
Geode Capital Management
FMR
Loomis, Sayles and
Invesco
Ubs Global Asset Management Americas

View all funds holding Ligand Pharmaceuticals In